Diclofenac and hyaluronic acid combination treatment for oral leukpoplakia

1. A method of treating a patient with oral leukoplakia or at risk of developing oral leukoplakia, the method comprising:

administering a therapeutically effective amount of an oral gel composition comprising a nonsteroidal anti-inflammatory drug (NSAID) or a pharmaceutically acceptable salt thereof, hyaluronic acid or a pharmaceutically acceptable salt thereof, a gelling agent or thickener, and a flavoring agent and/or sweetener to a mucosal tissue or an affected portion thereof; and

inserting, in a mouth of the patient, a device comprising:

an oral retention portion that is suitably shaped to be retained in an oral cavity for a predetermined treatment period, an upper bite flange and a lower bite flange extending from an interior surface of the oral retention portion forming a bite wedge along each end defined by oral retention portion, and a covering portion that extends from the retention portion, the covering portion has at least one surface that contacts the mucosal tissue being treated with the oral gel composition therapeutic agent.

2. The method of claim 1 , wherein administering the therapeutically effective amount of the oral gel composition comprises:

administering the therapeutically effective amount of the oral gel composition to a patient with oral leukoplakia.

3. The method of claim 2 , wherein administering the therapeutically effective amount of the oral gel composition comprises administering the therapeutically effective amount of the oral gel composition to a patient at risk of developing oral leukoplakia.

4. The method of claim 3 , wherein administering the therapeutically effective amount of the oral gel composition comprises:

applying the oral gel composition to the mucosal tissue or a portion of the mucosal tissue prior to inserting the device in the mouth of the patient;

applying the oral gel composition to an outer surface of the device prior to inserting the device in the mouth of the patient and then inserting the device in the mouth of the patient; or

prior to inserting the device in the mouth of the patient:

applying a first amount of the oral gel composition to the mucosal tissue or the portion of the mucosal tissue; and

applying a second amount of the oral gel composition to the outer surface of the device and then inserting the device in the mouth of the patient.

5. The method of claim 4 , wherein the oral device comprises:

a fitting portion having an arcuate shape corresponding to a dental arche of the patient and at least one covering portion, the covering portion having a respective outer surface, an upper wing portion and a lower wing portion;

at least one bite flange extending from an interior surface of the fitting portion;

an upper ledge extending from the interior surface of the fitting portion and following the arc of the fitting portion,

wherein an upper surface of the upper ledge and an upper surface of the at least one bite flange are continuous with one another,

wherein the at least one covering section is more flexible than the fitting portion, and wherein a portion of the respective outer surface of the at least one covering portion is in contact with the portion of the mucosal tissue.

6. The method of claim 5 , wherein the at least one covering portion has a surface that contacts and rests against an affected portion of a tongue of the patient.

7. The method of claim 6 , wherein the at least one covering portion has a surface that contacts and rests against a ventral side of the tongue.

8. The method of claim 6 , wherein the at least one covering portion has a surface that contacts and rests against one or both sides of the tongue.

9. The method of claim 6 , further comprising cutting away covering portions that are designed to cover portions of the mucosa that do not have oral leukoplakia, for patient comfort.